DK1446733T3 - Glycosylphosphatidylinositol indeholdende polypeptider - Google Patents

Glycosylphosphatidylinositol indeholdende polypeptider

Info

Publication number: DK1446733T3
Authority: DK; Denmark
Prior art keywords: polypeptides; glycosylphosphatidylinositol; containing polypeptides; relates; domain
Prior art date: 2001-10-13

Application number

DK02801405T

Other languages

English (en)

Inventor

Richard Ross

Original Assignee

Asterion Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-10-13

Filing date

2002-10-11

Publication date

2009-10-26

2001-10-13 Priority claimed from GB0124620A external-priority patent/GB2380735A/en

2002-01-16 Priority claimed from GB0200904A external-priority patent/GB0200904D0/en

2002-08-14 Priority claimed from GB0218889A external-priority patent/GB0218889D0/en

2002-10-11 Application filed by Asterion Ltd filed Critical Asterion Ltd

2009-10-26 Application granted granted Critical

2009-10-26 Publication of DK1446733T3 publication Critical patent/DK1446733T3/da

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Genetics & Genomics (AREA)
Immunology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Zoology (AREA)
Molecular Biology (AREA)
Biophysics (AREA)
Biochemistry (AREA)
Cell Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Diabetes (AREA)
Gastroenterology & Hepatology (AREA)
Toxicology (AREA)
Biomedical Technology (AREA)
General Engineering & Computer Science (AREA)
Endocrinology (AREA)
Rheumatology (AREA)
Wood Science & Technology (AREA)
Biotechnology (AREA)
Transplantation (AREA)
Emergency Medicine (AREA)
Pain & Pain Management (AREA)
Psychiatry (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Neurosurgery (AREA)
Obesity (AREA)

DK02801405T 2001-10-13 2002-10-11 Glycosylphosphatidylinositol indeholdende polypeptider DK1446733T3 (da)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
GB0124620A GB2380735A (en)	2001-10-13	2001-10-13	GPI-anchored proteins
GB0200904A GB0200904D0 (en)	2002-01-16	2002-01-16	Anchors-2
GB0218889A GB0218889D0 (en)	2002-08-14	2002-08-14	Anchors 3
PCT/GB2002/004665 WO2003034275A2 (en)	2001-10-13	2002-10-11	Chimeric glycosylphosphatidylinositol containing peptides

Publications (1)

Publication Number	Publication Date
DK1446733T3 true DK1446733T3 (da)	2009-10-26

Family

ID=27256298

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK02801405T DK1446733T3 (da)	2001-10-13	2002-10-11	Glycosylphosphatidylinositol indeholdende polypeptider

Country Status (17)

Country	Link
US (1)	US7485713B2 (da)
EP (1)	EP1446733B1 (da)
JP (1)	JP4384492B2 (da)
KR (2)	KR20100039911A (da)
CN (1)	CN1568330A (da)
AT (1)	ATE442444T1 (da)
AU (1)	AU2002334161B2 (da)
CA (1)	CA2494706A1 (da)
DE (1)	DE60233674D1 (da)
DK (1)	DK1446733T3 (da)
ES (1)	ES2329228T3 (da)
HU (1)	HUP0401611A3 (da)
IL (1)	IL161296A0 (da)
NZ (1)	NZ532460A (da)
PL (1)	PL369953A1 (da)
PT (1)	PT1446733E (da)
WO (1)	WO2003034275A2 (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU2006304387A1 (en)	2005-10-14	2007-04-26	Medimmune, Llc	Cell display of antibody libraries
PT2532681E (pt) *	2005-12-20	2014-12-23	Sbi Biotech Co Ltd	Anticorpos anti-ilt7
WO2007098547A1 (en) *	2006-03-01	2007-09-07	Apollo Life Sciences Limited	A molecule and chimeric molecules thereof
GB0618082D0 (en) *	2006-09-14	2006-10-25	Asterion Ltd	Growth factor
EP2068914A4 (en) *	2007-02-09	2011-07-20	Medimmune Llc	PRESENTATION OF ANTIBODY BANK BY PLASMA MEMBRANES OF YEAST CELLS
CN103694337B (zh) *	2008-02-08	2016-03-02	Ambrx公司	经修饰瘦素多肽和其用途
US11274139B2 (en)	2013-04-12	2022-03-15	Evox Therapeutics Ltd	Therapeutic delivery vesicles

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5374548A (en) *	1986-05-02	1994-12-20	Genentech, Inc.	Methods and compositions for the attachment of proteins to liposomes using a glycophospholipid anchor
US4857637A (en) *	1986-05-07	1989-08-15	Genentech, Inc.	Methods and compositions for immunologically modulating growth hormone receptor activity
US5057417A (en) *	1987-06-12	1991-10-15	Genentech, Inc.	Compositions and methods for the synthesis of growth hormone receptor and growth hormone binding protein
US6113917A (en) *	1995-04-25	2000-09-05	Rmf Dictagene S.A.	Modified polypeptides for enhanced immunogenicity
TW562807B (en)	1997-04-01	2003-11-21	Chugai Pharmaceutical Co Ltd	Novel secretory membrane protein
EP1001990A4 (en)	1997-06-26	2001-12-19	Immunex Corp	PROTEIN BINDING TO TRAIL PROTEIN
WO1999060113A1 (fr) *	1998-05-20	1999-11-25	Chugai Seiyaku Kabushiki Kaisha	Nouveau procede d'isolation de gene
EP1171579A4 (en)	1999-03-24	2002-07-31	Human Genome Sciences Inc	TR9 HUMAN RECEPTOR OF TUMOR NECROSIS FACTORS
JP3815409B2 (ja) *	2002-08-29	2006-08-30	ブラザー工業株式会社	電話端末、通話システムおよび端末制御プログラム

2002
- 2002-10-11 US US10/492,403 patent/US7485713B2/en not_active Expired - Fee Related
- 2002-10-11 JP JP2003536934A patent/JP4384492B2/ja not_active Expired - Lifetime
- 2002-10-11 WO PCT/GB2002/004665 patent/WO2003034275A2/en active Application Filing
- 2002-10-11 NZ NZ532460A patent/NZ532460A/en not_active IP Right Cessation
- 2002-10-11 KR KR1020107007082A patent/KR20100039911A/ko not_active Application Discontinuation
- 2002-10-11 PT PT02801405T patent/PT1446733E/pt unknown
- 2002-10-11 HU HU0401611A patent/HUP0401611A3/hu unknown
- 2002-10-11 DE DE60233674T patent/DE60233674D1/de not_active Expired - Lifetime
- 2002-10-11 AU AU2002334161A patent/AU2002334161B2/en not_active Ceased
- 2002-10-11 EP EP02801405A patent/EP1446733B1/en not_active Expired - Lifetime
- 2002-10-11 DK DK02801405T patent/DK1446733T3/da active
- 2002-10-11 CN CNA028202775A patent/CN1568330A/zh active Pending
- 2002-10-11 KR KR1020047005419A patent/KR20050035511A/ko active IP Right Grant
- 2002-10-11 ES ES02801405T patent/ES2329228T3/es not_active Expired - Lifetime
- 2002-10-11 IL IL16129602A patent/IL161296A0/xx not_active IP Right Cessation
- 2002-10-11 AT AT02801405T patent/ATE442444T1/de not_active IP Right Cessation
- 2002-10-11 PL PL02369953A patent/PL369953A1/xx unknown
- 2002-10-11 CA CA002494706A patent/CA2494706A1/en not_active Abandoned

Also Published As

Publication number	Publication date
PT1446733E (pt)	2009-09-28
DE60233674D1 (de)	2009-10-22
JP2005505307A (ja)	2005-02-24
US20050059577A1 (en)	2005-03-17
US7485713B2 (en)	2009-02-03
JP4384492B2 (ja)	2009-12-16
HUP0401611A3 (en)	2010-01-28
CA2494706A1 (en)	2003-04-24
HUP0401611A2 (hu)	2004-11-29
ES2329228T3 (es)	2009-11-24
AU2002334161B2 (en)	2007-03-29
IL161296A0 (en)	2004-09-27
KR20100039911A (ko)	2010-04-16
PL369953A1 (en)	2005-05-02
NZ532460A (en)	2005-10-28
EP1446733B1 (en)	2009-09-09
KR20050035511A (ko)	2005-04-18
WO2003034275A2 (en)	2003-04-24
WO2003034275A3 (en)	2003-11-27
EP1446733A2 (en)	2004-08-18
CN1568330A (zh)	2005-01-19
ATE442444T1 (de)	2009-09-15

Publication	Publication Date	Title
YU19903A (sh)	2006-05-25	Novi receptor nukleinskih kiselina i polipeptida
CY1112101T1 (el)	2015-11-04	Νευροτροφικοι παραγοντες
WO2005005462A3 (en)	2006-01-26	Blys antagonists and uses thereof
TR200102191T2 (tr)	2001-12-21	HER-2/neu füzyon proteinleri.
SE0101675D0 (sv)	2001-05-11	Novel composition
WO2002089738A3 (en)	2003-04-10	Proteomimetic compounds and methods
DK1229047T3 (da)	2005-02-21	IL-1-receptor-fusionsproteiner anvendt som antagonister og fremgangsmåder til fremstilling og anvendelse
CY1111750T1 (el)	2015-10-07	Νευροτροφικοι παραγοντες
DE69933696D1 (de)	2006-11-30	Cytokinrezeptor-kette
DK1446733T3 (da)	2009-10-26	Glycosylphosphatidylinositol indeholdende polypeptider
ATE390482T1 (de)	2008-04-15	Interleukin-1 hy2. mittel und verfahren
TW200508246A (en)	2005-03-01	Anti-dengue virus antibodies, compositions, methods and uses
DE60133366D1 (de)	2008-05-08	Irak-4 zusammensetzungen und deren verwendungen
DK0793721T3 (da)	2006-01-30	Peptider, der er i stand til at binde sig til GAP-proteinets SH3-domæne, nukleotidsekvenser, der koder derfor, fremstilling og anvendelse deraf
ATE247130T1 (de)	2003-08-15	Inhibitoren für den urokinaserezeptor
TR200102655T2 (tr)	2002-04-22	Dört L. infantum proteininin antijen belirleyicilerini kodlayan kimerik gen.
AR022150A1 (es)	2002-09-04	Acidos nucleicos derivados de monocitos y composiciones y metodos relacionados
IL162601A0 (en)	2005-11-20	Raf/ras binding proteins, their preparation and use
CY1109904T1 (el)	2014-09-10	Προαγωγεας της il-18bp, η παρασκευη και χρηση του
SG148195A1 (en)	2008-12-31	Plasmids coding for p185neu protein sequence variants and therapeutic uses thereof
BRPI0418335A (pt)	2007-05-02	ácido nucléico codificando uma proteìna de receptor de postaglandina e métodos de uso desta
DE50206254D1 (de)	2006-05-18	Pna-konjugat zur therapie der chronischen myeloischen leukämie (cml)
WO2005046577A3 (en)	2006-02-02	Human prostaglandin ep1 receptor variants and methods of using same
DE60031262D1 (de)	2006-11-23	Menschliche promotoren des gaba b-rezeptors 1